flutamide has been researched along with androstane-3,17-diol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirschner, MA; Luthold, WW; Marcondes, JA; Minnani, SL; Samojlik, E; Wajchenberg, BL | 1 |
| de Launoit, Y; Dufour, M; Labrie, F; Simard, J; Veilleux, R | 1 |
| Barbolt, TA; Dube, JY; Egy, MA; Frenette, G; Juniewicz, PE; Tremblay, RR | 1 |
| Bélanger, A; Brochu, M; Cusan, L; Dupont, A; Labrie, F | 2 |
| Baroncelli, GI; Battini, R; Bertelloni, S; Costa, S; Saggese, G; Sorrentino, MC | 1 |
| Diamanti-Kandarakis, E; Duleba, AJ; Mitrakou, A; Raptis, S; Tolis, G | 1 |
| Chang, C; Lardy, H; Messing, E; Miyamoto, H; Yeh, S | 1 |
| Falsetti, L; Gambera, A | 1 |
| Castello, R; Dorizzi, R; Fortunato, A; Moghetti, P; Muggeo, M; Negri, C; Spiazzi, GG; Tosi, F | 1 |
| Reddy, DS | 1 |
| Handa, RJ; Hinds, LR; Lund, TD | 1 |
| Frye, CA; Rhodes, M; Ryan, A | 1 |
| Jian, K; Reddy, DS | 1 |
3 trial(s) available for flutamide and androstane-3,17-diol
| Article | Year |
|---|---|
Androgen-receptor blockade does not impair bone mineral density in adolescent females.
Topics: Absorptiometry, Photon; Acne Vulgaris; Adolescent; Adult; Analysis of Variance; Androgen Antagonists; Androgen Receptor Antagonists; Androstane-3,17-diol; Bone Density; Dehydroepiandrosterone; Female; Flutamide; Follicle Stimulating Hormone; Hirsutism; Humans; Lumbar Vertebrae; Luteinizing Hormone; Sex Hormone-Binding Globulin | 1997 |
Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Androstane-3,17-diol; Body Mass Index; Enzyme Inhibitors; Female; Finasteride; Flutamide; Hair; Hirsutism; Humans; Testosterone; Treatment Outcome | 1999 |
Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.
Topics: Adult; Androgen Antagonists; Androgens; Androstane-3,17-diol; Biomarkers; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Flutamide; Hirsutism; Humans; Prostate-Specific Antigen; Spironolactone; Testosterone | 2000 |
11 other study(ies) available for flutamide and androstane-3,17-diol
| Article | Year |
|---|---|
Treatment of hirsutism in women with flutamide.
Topics: Adult; Analysis of Variance; Androstane-3,17-diol; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 1992 |
Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells.
Topics: Androgens; Androstane-3,17-diol; Binding, Competitive; Cell Cycle; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Antagonism; Estradiol; Estrogen Antagonists; Estrone; Flow Cytometry; Flutamide; Humans; In Vitro Techniques; Male; Metribolone; Piperidines; Prostatic Neoplasms; Raloxifene Hydrochloride; Tamoxifen; Testosterone; Time Factors; Tumor Cells, Cultured | 1991 |
Effects of androgen and antiandrogen treatment on canine prostatic arginine esterase.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenes; Anilides; Animals; Azasteroids; Capsules; Carboxylic Ester Hydrolases; Dogs; Dose-Response Relationship, Drug; Estradiol; Finasteride; Flutamide; Hyperplasia; Injections, Intramuscular; Male; Nitriles; Pregnanes; Prostate; Prostatectomy; Pyrazoles; Tosyl Compounds | 1990 |
Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate.
Topics: Aged; Aminoglutethimide; Androstane-3,17-diol; Androstanols; Androsterone; Anilides; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Flutamide; Glucuronates; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms | 1987 |
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dehydroepiandrosterone; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Kinetics; Luteinizing Hormone; Male; Pregnenolone; Progesterone; Prolactin; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1988 |
The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androstane-3,17-diol; Androstenedione; Cholesterol; Dehydroepiandrosterone Sulfate; Female; Flutamide; Humans; Hyperlipidemias; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Liver Function Tests; Obesity; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 1998 |
Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells.
Topics: Androgens; Androstane-3,17-diol; Androstenediol; Anilides; Flutamide; Humans; Male; Mutation; Nitriles; Nuclear Receptor Coactivators; Oncogene Proteins; Prostatic Neoplasms; Protein Conformation; Receptors, Androgen; Steroids; Testosterone; Tosyl Compounds; Trans-Activators; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 1998 |
Anticonvulsant activity of the testosterone-derived neurosteroid 3alpha-androstanediol.
Topics: Androgen Antagonists; Androstane-3,17-diol; Animals; Anticonvulsants; Carbolines; Convulsants; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Flutamide; Male; Mice; Mice, Inbred C57BL; Pentylenetetrazole; Picrotoxin; Receptors, Androgen; Receptors, GABA-A; Seizures; Testosterone | 2004 |
The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus.
Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Animals; Dihydrotestosterone; Drug Implants; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Flutamide; Hypothalamo-Hypophyseal System; Immobilization; Male; Neurons; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Stress, Physiological; Tamoxifen | 2006 |
Antiseizure effects of 3alpha-androstanediol and/or 17beta-estradiol may involve actions at estrogen receptor beta.
Topics: Analysis of Variance; Androgen Antagonists; Androstane-3,17-diol; Animals; Anticonvulsants; Disease Models, Animal; Estradiol; Estrogen Receptor beta; Flutamide; Male; Pentylenetetrazole; Rats; Rats, Long-Evans; Reaction Time; Seizures | 2009 |
The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors.
Topics: Androgen Antagonists; Androstane-3,17-diol; Animals; CA1 Region, Hippocampal; Data Interpretation, Statistical; Evoked Potentials; Flutamide; GABA Modulators; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Kindling, Neurologic; Male; Mice; Mice, Inbred C57BL; Psychomotor Performance; Pyramidal Cells; Receptors, GABA-A; Seizures | 2010 |